We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioLineRx Announces Initiation of CE Mark Registration Trial for BCM (BL-1040)

Product News   Jan 06, 2012

 
BioLineRx Announces Initiation of CE Mark Registration Trial for BCM (BL-1040)
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

READ MORE

Vaccine Against COVID-19 Advances to Late-stage Development

Product News

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.

READ MORE

GSK and Clover Biopharmaceuticals COVID-19 Vaccine Begins Human Clinical Trials

Product News

GSK’s scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered into human clinical trials.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE